You can buy or sell Clementia and other stocks, options, ETFs, and crypto commission-free!
Clementia Pharmaceuticals Inc. Common Shares, also called Clementia, is a biopharmaceutical company, which focuses on exploiting the science of novel retinoic acid receptor gamma agonists to address bone disease and involves in development and commercialization of treatments for people living with rare diseases. Read More Clementia Pharmaceuticals was founded by Clarissa Desjardins and Jean-Claude Tardif on November 5, 2010 and is headquartered in Montreal, Canada.
52 Week High
52 Week Low
-$0.44 per share
Expected Mar 27, Pre-Market